| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |